Zhejiang Peptites Biotech Co., Ltd. (ZPC) is a national-level specialized, high-end and innovation-driven “Little Giant” enterprise focusing on the research, production and application of peptides. ZPC has one National Postdoctoral Research Workstation, one Shaoxing Academician Expert Workstation, one Provincial Enterprise Research Institute, and the first Zhejiang Peptide Synthesis Engineering Research Center. ZPC is one of the leading enterprises in the large-scale production of peptides in China. As of November 2025, it has obtained 108 authorized patents. ZPC has built a development strategy of “one body with two wings and two-wheel drive”. The business centers on pharmaceutical peptides and related technical services, supported by two wings: cosmetic peptides and other peptide applications. This structure creates a “two-wheel drive” model, driven by both drug and non-drug peptide portfolios, as well as by product innovation capabilities and extensive market channels and client base.
ZPC's production system strictly adheres to international standards, having obtained FDA certification, as well as multiple management system certifications including HALAL, EcoVadis, and ISO, which ensures the full-lifecycle compliance and reliability of products.
More than 60 peptide APIs are widely used in the treatment of obesity, diabetes and gastrointestinal diseases, with several core high-demand peptide APIs having been filed or approved in multiple countries. Over 40 cosmetic peptides cover multiple application fields including anti-wrinkle, anti-aging, repair, and whitening.
ZPC possesses large-scale production facilities with an annual capacity of 8,000 kg of peptide powder and 2,000 tons of peptide solution. This ensures consistent and timely product supply at competitive prices, effectively meeting the procurement requirements of global clients.
ZPC has successfully expanded its global market presence and has established strategic partnerships with internationally recognized enterprises. ZPC’s products are now exported to key international markets including US, EU, Canada, Korea, Japan, and Russia.
